Report Detail

Other Global Targeted RNA Sequencing Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM3129866
  • |
  • 15 March, 2019
  • |
  • Global
  • |
  • 120 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.

Scope of the Report:
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.
Market competition is not intense. Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The worldwide market for Targeted RNA Sequencing is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Targeted RNA Sequencing in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Thermo Fisher
Illumina
Roche Holdings
BGI
Eurofins
LabCorp
Berry Genomics
Macrogen
GENEWIZ

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
enrichment approaches
amplicon-based approaches

Market Segment by Applications, can be divided into
Research Institutes
Hospitals & Clinics
Biotechnology Company
Diagnostic Lab

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Targeted RNA Sequencing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Targeted RNA Sequencing, with price, sales, revenue and global market share of Targeted RNA Sequencing in 2017 and 2018.
Chapter 3, the Targeted RNA Sequencing competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Targeted RNA Sequencing breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Targeted RNA Sequencing market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Targeted RNA Sequencing sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Targeted RNA Sequencing Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 enrichment approaches
      • 1.2.2 amplicon-based approaches
    • 1.3 Market Analysis by Applications
      • 1.3.1 Research Institutes
      • 1.3.2 Hospitals & Clinics
      • 1.3.3 Biotechnology Company
      • 1.3.4 Diagnostic Lab
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Thermo Fisher
      • 2.1.1 Business Overview
      • 2.1.2 Targeted RNA Sequencing Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Thermo Fisher Targeted RNA Sequencing Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Illumina
      • 2.2.1 Business Overview
      • 2.2.2 Targeted RNA Sequencing Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Illumina Targeted RNA Sequencing Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Roche Holdings
      • 2.3.1 Business Overview
      • 2.3.2 Targeted RNA Sequencing Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Roche Holdings Targeted RNA Sequencing Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 BGI
      • 2.4.1 Business Overview
      • 2.4.2 Targeted RNA Sequencing Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 BGI Targeted RNA Sequencing Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Eurofins
      • 2.5.1 Business Overview
      • 2.5.2 Targeted RNA Sequencing Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Eurofins Targeted RNA Sequencing Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 LabCorp
      • 2.6.1 Business Overview
      • 2.6.2 Targeted RNA Sequencing Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 LabCorp Targeted RNA Sequencing Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Berry Genomics
      • 2.7.1 Business Overview
      • 2.7.2 Targeted RNA Sequencing Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Berry Genomics Targeted RNA Sequencing Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Macrogen
      • 2.8.1 Business Overview
      • 2.8.2 Targeted RNA Sequencing Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Macrogen Targeted RNA Sequencing Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 GENEWIZ
      • 2.9.1 Business Overview
      • 2.9.2 Targeted RNA Sequencing Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 GENEWIZ Targeted RNA Sequencing Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Targeted RNA Sequencing Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Targeted RNA Sequencing Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Targeted RNA Sequencing Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Targeted RNA Sequencing Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Targeted RNA Sequencing Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Targeted RNA Sequencing Market Analysis by Regions

    • 4.1 Global Targeted RNA Sequencing Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Targeted RNA Sequencing Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Targeted RNA Sequencing Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Targeted RNA Sequencing Sales and Growth Rate (2014-2019)
    • 4.3 Europe Targeted RNA Sequencing Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Targeted RNA Sequencing Sales and Growth Rate (2014-2019)
    • 4.5 South America Targeted RNA Sequencing Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Targeted RNA Sequencing Sales and Growth Rate (2014-2019)

    5 North America Targeted RNA Sequencing by Country

    • 5.1 North America Targeted RNA Sequencing Sales, Revenue and Market Share by Country
      • 5.1.1 North America Targeted RNA Sequencing Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Targeted RNA Sequencing Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Targeted RNA Sequencing Sales and Growth Rate (2014-2019)
    • 5.3 Canada Targeted RNA Sequencing Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Targeted RNA Sequencing Sales and Growth Rate (2014-2019)

    6 Europe Targeted RNA Sequencing by Country

    • 6.1 Europe Targeted RNA Sequencing Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Targeted RNA Sequencing Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Targeted RNA Sequencing Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Targeted RNA Sequencing Sales and Growth Rate (2014-2019)
    • 6.3 UK Targeted RNA Sequencing Sales and Growth Rate (2014-2019)
    • 6.4 France Targeted RNA Sequencing Sales and Growth Rate (2014-2019)
    • 6.5 Russia Targeted RNA Sequencing Sales and Growth Rate (2014-2019)
    • 6.6 Italy Targeted RNA Sequencing Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Targeted RNA Sequencing by Country

    • 7.1 Asia-Pacific Targeted RNA Sequencing Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Targeted RNA Sequencing Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Targeted RNA Sequencing Revenue and Market Share by Country (2014-2019)
    • 7.2 China Targeted RNA Sequencing Sales and Growth Rate (2014-2019)
    • 7.3 Japan Targeted RNA Sequencing Sales and Growth Rate (2014-2019)
    • 7.4 Korea Targeted RNA Sequencing Sales and Growth Rate (2014-2019)
    • 7.5 India Targeted RNA Sequencing Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Targeted RNA Sequencing Sales and Growth Rate (2014-2019)

    8 South America Targeted RNA Sequencing by Country

    • 8.1 South America Targeted RNA Sequencing Sales, Revenue and Market Share by Country
      • 8.1.1 South America Targeted RNA Sequencing Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Targeted RNA Sequencing Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Targeted RNA Sequencing Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Targeted RNA Sequencing Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Targeted RNA Sequencing Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Targeted RNA Sequencing by Countries

    • 9.1 Middle East and Africa Targeted RNA Sequencing Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Targeted RNA Sequencing Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Targeted RNA Sequencing Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Targeted RNA Sequencing Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Targeted RNA Sequencing Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Targeted RNA Sequencing Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Targeted RNA Sequencing Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Targeted RNA Sequencing Sales and Growth Rate (2014-2019)

    10 Global Targeted RNA Sequencing Market Segment by Type

    • 10.1 Global Targeted RNA Sequencing Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Targeted RNA Sequencing Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Targeted RNA Sequencing Revenue and Market Share by Type (2014-2019)
    • 10.2 enrichment approaches Sales Growth and Price
      • 10.2.1 Global enrichment approaches Sales Growth (2014-2019)
      • 10.2.2 Global enrichment approaches Price (2014-2019)
    • 10.3 amplicon-based approaches Sales Growth and Price
      • 10.3.1 Global amplicon-based approaches Sales Growth (2014-2019)
      • 10.3.2 Global amplicon-based approaches Price (2014-2019)

    11 Global Targeted RNA Sequencing Market Segment by Application

    • 11.1 Global Targeted RNA Sequencing Sales Market Share by Application (2014-2019)
    • 11.2 Research Institutes Sales Growth (2014-2019)
    • 11.3 Hospitals & Clinics Sales Growth (2014-2019)
    • 11.4 Biotechnology Company Sales Growth (2014-2019)
    • 11.5 Diagnostic Lab Sales Growth (2014-2019)

    12 Targeted RNA Sequencing Market Forecast (2019-2024)

    • 12.1 Global Targeted RNA Sequencing Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Targeted RNA Sequencing Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Targeted RNA Sequencing Market Forecast (2019-2024)
      • 12.2.2 Europe Targeted RNA Sequencing Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Targeted RNA Sequencing Market Forecast (2019-2024)
      • 12.2.4 South America Targeted RNA Sequencing Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Targeted RNA Sequencing Market Forecast (2019-2024)
    • 12.3 Targeted RNA Sequencing Market Forecast by Type (2019-2024)
      • 12.3.1 Global Targeted RNA Sequencing Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Targeted RNA Sequencing Market Share Forecast by Type (2019-2024)
    • 12.4 Targeted RNA Sequencing Market Forecast by Application (2019-2024)
      • 12.4.1 Global Targeted RNA Sequencing Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Targeted RNA Sequencing Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Targeted RNA Sequencing. Industry analysis & Market Report on Targeted RNA Sequencing is a syndicated market report, published as Global Targeted RNA Sequencing Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Targeted RNA Sequencing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,780.52
      4,170.78
      5,561.04
      3,229.44
      4,844.16
      6,458.88
      542,392.80
      813,589.20
      1,084,785.60
      290,823.60
      436,235.40
      581,647.20
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report